A Smarter Cancer Treatment, Beyond Biomarkers

February 21, 2025

Cancer treatment is an ongoing battle, with tumors constantly evolving and biomarker therapies benefiting only 8% of patients. Big Pharma’s approach—dividing patients into smaller groups fails to offer a scalable solution. Oncology CoPilot changes the game, using gene expression and AI to match patients with existing FDA-approved therapies, delivering effective treatment now. No more chasing mutations—this powerful tool is designed for tumor boards and oncologists to navigate complex cases and provide truly personalized care.

Here is our detailed pitch deck. Please feel free to reach out if you're interested.